Is Subcutaneous Route an Alternative to Intravenous Route for Mouse Contrast-Enhanced Magnetic Resonance Imaging at 1.5 T?

Figure 6

MIP view of the head of a mouse following SC (a) and IV (b) injection of MS-325 (Vasovist), and curves showing the delay from administration and duration of MR acquisition (see S1 and S2). Acquisition parameters were presented in (c).